Latin America Hypodermic Syringes and Needles Market
Latin America Hypodermic Syringes and Needles Market by Needles, Syringes & Region | Forecast 2023 to 2033
Increasing Incidence of Diseases and Allergies is projected to Drive Latin America Hypodermic Syringes and Needles Market Growth. FMI Surveys Market across 30+ Economies to Provide Ordered Market Research
An Overview of Latin America Hypodermic Syringes and Needles Market
Latin America hypodermic syringes and needles market size is likely to reach US$ 207.25 million in 2023 and is projected to be worth US$ 360.78 million by 2033. The market is likely to expand at a CAGR of 5.9% from 2023 to 2033.
Factors that Drive the Latin America Hypodermic Syringes and Needles Market
Novel advancements and increasing funds for healthcare enable people to opt for medical procedures.
A growing length of diabetic and asthma patients is one of the crucial market driving factors to flourish market at a significant rate. Healthcare experts generally use hypodermic needles but sometimes a few diabetic patients use them to take insulin shots.
Food allergies from seafood and milk along with nasal allergies are a few common allergies in the population. The increasing prevalence of these allergies is estimated to grow the market considerably.
Increase in the volume of surgeries, the growing demand for syringes in mass vaccination, and the surge in chronic disorders.
Hypodermic syringes are favored as compared to after-filled syringes as they provide fixed dosages of the drug and ease in usability.
The global hypodermic syringes market is anticipated to fuel under the backdrop of the global pharmaceutical industry during the projection period.
Medication errors and reduced dosing are also among the key factors increasing the demand for hypodermic syringes.
The conventional syringes were developed with the use of glass barrels and glass rods which were relatively costly as compared to plastic-based hypodermic syringes increasing the global sales of hypodermic syringes.
Increasing trend of people getting vaccinated outside hospitals such as in pharmacies, airport booths, schools as well as community centers.
During the pandemic, COVID-19 patients needed to opt for blood sampling.
Attributes
Details
Latin America Hypodermic Syringes and Needles Market CAGR (2023 to 2033)
5.9%
Latin America Hypodermic Syringes and Needles Market Size (2023)
US$ 207.25 million
Latin America Hypodermic Syringes and Needles Market Size (2033)
US$ 360.78 million
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Latin America Hypodermic Syringes and Needles Market Historical Analysis (2018 to 2022) Vs. Forecast Outlook (2023 to 2033)
Historical Value (2022)
US$ 196.07 million
Forecast Value (2033)
US$ 360.78 million
Latin America hypodermic syringes and needles market yielded US$ 196.07 million in 2022 and is expected to reach US$ 360.78 million in 2033. The syringes segment was the leading segment in the year 2022 because of the growing adoption rate and high cost compared to needles.
Government initiatives and dosing errors linked with syringes have increased the sales of hypodermic syringes in healthcare markets. Aggressive price ranges and new schemes work as key aspects to accelerate industry growth. For instance, countries in Latin America were hardest hit during the pandemic, therefore the region collaborated with ECLAC (Economic Commission for Latin America and the Caribbean) to prepare a ‘Plan for Self-sufficiency’. Through this initiative, the government aims to strengthen its science and technology capabilities.
An increase in the efforts by government organizations such as the United Nations and the WHO to create awareness about safe drug delivery practices and reduce the spread of diseases is predicted to lead to the growth of the industry. Several initiatives are taken by these organizations for safe drug delivery.
Rising competition enhancing businesses to adapt as well as explore according to the recent trends and dynamics is also projected to flourish the hypodermic syringes market.
Comparative View of Access Control Market
Latin America Hypodermic Syringes and Needles Market:
Attributes
Latin America Hypodermic Syringes and Needles Market
CAGR (2023 to 2033)
5.9%
Market Value (2033)
US$ 360.78 million
Growth Factor
Rising incidences of chronic disorder, growing demand for hypodermic syringes and needles, and increasing cases of surgeries.
Opportunity
Important advancements are anticipated to bring new opportunities for the market.
Key Trends
The expansion of manufacturing capabilities by the key manufacturers is bringing strong revenue share for market growth.
Syringe Trays Market:
Attributes
Syringe Trays Market
CAGR (2023 to 2033)
11.4%
Market Value (2033)
US$ 52.92 billion
Growth Factor
The introduction of novel forms of injectable and increasing healthcare facilities
Opportunity
Growing demand for syringe trays in the global market is bringing new opportunities for the syringe tray market players.
Key Trends
Well-developed manufacturing unit employing current technologies and high-quality material is the new trend in the market.
Syringe Filling Machine Market:
Attributes
Syringe Filling Machine Market
CAGR (2023 to 2033)
3.7%
Market Value (2033)
US$ 214.8 million
Growth Factor
Improvements in the refillable syringe sector and the developing automation and biotechnology industry
Opportunity
Pharmaceutical industry technological improvements are bringing new opportunities for market growth.
Key Trends
The introduction of additional syringe sizes in future periods is shaping the growth trend for the market.
Find your sweet spots for generating winning opportunities in this market.
Increasing Diabetic Patients is Estimated to Drive the Latin America Hypodermic Syringes and Needles Market
Diabetes is one of the leading causes of death caused due to a chronic non-communicable illness. It presents a main health crisis in several countries of Latin America. If compared with other western countries, there is an uneven surge of diabetes in Latin America. It may be because of the environmental, genetic, and socioeconomic predisposition of the population of this region for different risk factors of type 2 diabetes mellitus including obesity, insulin resistance, and other metabolic disorders.
People suffering from diabetes might increase by 48% and is anticipated to reach 49 billion by 2045 according to the International Diabetes Federation’s 2021 statistics. It indicates that there is an increasing prevalence of diabetes by 25%. As increasing diabetic patients is anticipated to fuel Latin America hypodermic syringes and needles market growth.
Category-wise Insights
Based on type, the syringes segment recorded a high revenue share in 2022 by dominating the market due to the rising adoption of syringes in different procedures and increasing surgery numbers. Moreover, soaring chronic diseases like diabetes are bolstering the growth of the hypodermic syringes and needles market.
Increase the release of novel products by the leading players to fulfill the rising demand, strengthen their position and expand the product portfolio. However, the needles segment is projected to witness maximum growth capturing a high CAGR rate during the forthcoming years. An increase in the use of needles for delivering vaccines and drugs to patients and collecting blood samples is predicted to push sales of needles.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Insights
Brazil recorded a high revenue share in 2022. The country witnessed high growth due to the factors such as the increase in hospitals and the rising prevalence of different diseases including Zika virus, TB, malaria, and typhoid. The expansion in patients getting hospitalized is projected to propel the demand for hypodermic needles and syringes. In order to get further treatment for these diseases, pathogenic testing, as well as blood sampling is required.
The continuous prevalence of diseases that can be managed through only vaccination is estimated to fuel Venezuela's market growth during the forecast period. For example, more than 7,300 measles cases have been recorded since June 2017 in the country, counting nearly 64 deaths and 5,500 confirmed cases in September 2018 according to the Pan American Health Organization. This outburst has spread in this region’s all other countries, recording more than 10,000 alleged cases of measles in Brazil. It calls for the increasing demand for hypodermic syringes and needles in the region for vaccination during the estimation period.
Surging cases of influenza and COVID-19 again in the region have considerably increased the demand for hypodermic syringes and needles.
Competitive Analysis with Key Market Share Insights
Key players in the market focus on getting a competitive edge in the market with the adoption of effective strategies. These players aim at taking different strategic initiatives including novel product releases, mergers, collaboration, and acquisitions. These initiatives allow key players to reinforce their market position. Along with key players, manufacturers also aim at making investments in expanding their manufacturing capabilities to meet the rising demand for types and obtain a high revenue share in the market.
The key players upsurge the call to another height through marketing strategies. Implementation of advanced technologies and government initiatives upsurges the market expansion further.
Lifelong Meditech Private Limited: The Lifelong group expanded into manufacturing as well as the marketing of medical disposables and devices in 2005. It is specialized in manufacturing Sterile Hypodermic Single Use Syringes and Sterile Hypodermic Single Use Needles.
Cardinal Health: Cardinal Health is specialized in providing safety syringes and needles such as Monoject™ Magellan™ Hypodermic Safety Needles and Monoject™ Magellan™ Insulin and Tuberculin Safety Syringes.
Monoject™ Magellan™ Hypodermic Safety Needles are made with a strong safety shield covering the complete needle tip and cannula.
The Monoject™ Magellan™ insulin and tuberculin safety syringes are vital needle-based protection solutions that advance clinician efficiency as well as increase protection.
BD introduced a next-generation glass Prefillable Syringe (PFS) in September 2022, which provides new as well as strong criteria for processability, contamination, cosmetics, and integrity.
Nipro Corporation has introduced its new set of hypodermic syringes called hypodermic needle-pro devices, which have an array of clinical applications fueling the demand for hypodermic syringes.
Terumo Corporation has launched its hypodermic syringes with a needle that has an integrated plunger stop which helps in preventing the plunger from being pulled out.
A few of the leading players operating in the Latin America hypodermic syringes and needles market are given below
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Trends, Revenue Forecast, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Market Segmentation
Needles:
16-18G
19-21G
22-25G
26-29G
30-32G
Syringes:
1 to 5 ml
6 to 10 ml
11 to 15 ml
16 to 20 ml
21 to 25 ml
26 to 30 ml
31 to 35 ml
36 to 40 ml
41 to 45 ml
46 to 50 ml
By Region:
Latin America
Mexico
Argentina
Brazil
Chile
Ecuador
Uruguay
Venezuela
Colombia
Bolivia
Peru
Frequently Asked Questions
Which Countries Dominate the Latin America Hypodermic Syringes and Needles Market?
Brazil and Mexico dominate the global market.
What is the Growth Forecast for the Latin America Hypodermic Syringes and Needles Market?
The market is forecast to register a CAGR of 5.9% through 2033.
How is the Historical Performance of the Market?
From 2018 to 2022, the market grew at a CAGR of 5.9%.
Which is the Top Trend in the Latin America Hypodermic Syringes and Needles Market?
Technological advancement disrupts the current market trends.
What is the Projected Size of the Market by 2033?
The global market size is to reach US$ 360.78 million by 2033.
Table of Content
1. Executive Summary | Latin America Hypodermic Syringes and Needles Market
1.1. Latin America Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Needles
5.3.1.1. 16-18G
5.3.1.2. 19-21G
5.3.1.3. 22-25G
5.3.1.4. 26-29G
5.3.1.5. 30-32G
5.3.2. Syringes
5.3.2.1. 1-5ml
5.3.2.2. 6-10ml
5.3.2.3. 11-15ml
5.3.2.4. 16-20ml
5.3.2.5. 21-25ml
5.3.2.6. 26-30ml
5.3.2.7. 31-35ml
5.3.2.8. 36-40ml
5.3.2.9. 41-45ml
5.3.2.10. 46-50ml
5.3.3. Combination
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Users
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End Users, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Users, 2023 to 2033
6.3.1. Hospital
6.3.2. Diabetic Patients
6.3.3. Family Practitioners
6.3.4. Psychiatry
6.3.5. Others
6.4. Y-o-Y Growth Trend Analysis By End Users, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End Users, 2023 to 2033
7. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. Latin America
7.4. Market Attractiveness Analysis By Region
8. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Argentina
8.2.1.4. Colombia
8.2.1.5. Chile
8.2.1.6. Uruguay
8.2.1.7. Venezuela
8.2.1.8. Bolivia
8.2.1.9. Peru
8.2.1.10. Ecuado
8.2.2. By Type
8.2.3. By End Users
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.3.3. By End Users
8.4. Key Takeaways
9. Key Countries Hypodermic Syringes And Needles Market Analysis
9.1. Brazil
9.1.1. Pricing Analysis
9.1.2. Market Share Analysis, 2022
9.1.2.1. By Type
9.1.2.2. By End Users
9.2. Mexico
9.2.1. Pricing Analysis
9.2.2. Market Share Analysis, 2022
9.2.2.1. By Type
9.2.2.2. By End Users
9.3. Argentina
9.3.1. Pricing Analysis
9.3.2. Market Share Analysis, 2022
9.3.2.1. By Type
9.3.2.2. By End Users
9.4. Colombia
9.4.1. Pricing Analysis
9.4.2. Market Share Analysis, 2022
9.4.2.1. By Type
9.4.2.2. By End Users
9.5. Chile
9.5.1. Pricing Analysis
9.5.2. Market Share Analysis, 2022
9.5.2.1. By Type
9.5.2.2. By End Users
9.6. Uruguay
9.6.1. Pricing Analysis
9.6.2. Market Share Analysis, 2022
9.6.2.1. By Type
9.6.2.2. By End Users
9.7. Venezuela
9.7.1. Pricing Analysis
9.7.2. Market Share Analysis, 2022
9.7.2.1. By Type
9.7.2.2. By End Users
9.8. Bolivia
9.8.1. Pricing Analysis
9.8.2. Market Share Analysis, 2022
9.8.2.1. By Type
9.8.2.2. By End Users
9.9. Peru
9.9.1. Pricing Analysis
9.9.2. Market Share Analysis, 2022
9.9.2.1. By Type
9.9.2.2. By End Users
9.10. Ecuado
9.10.1. Pricing Analysis
9.10.2. Market Share Analysis, 2022
9.10.2.1. By Type
9.10.2.2. By End Users
10. Market Structure Analysis
10.1. Competition Dashboard
10.2. Competition Benchmarking
10.3. Market Share Analysis of Top Players
10.3.1. By Regional
10.3.2. By Type
10.3.3. By End Users
11. Competition Analysis
11.1. Competition Deep Dive
11.1.1. Smiths Medical
11.1.1.1. Overview
11.1.1.2. Product Portfolio
11.1.1.3. Profitability by Market Segments
11.1.1.4. Sales Footprint
11.1.1.5. Strategy Overview
11.1.1.5.1. Marketing Strategy
11.1.2. B. Braun Medical, Inc.
11.1.2.1. Overview
11.1.2.2. Product Portfolio
11.1.2.3. Profitability by Market Segments
11.1.2.4. Sales Footprint
11.1.2.5. Strategy Overview
11.1.2.5.1. Marketing Strategy
11.1.3. Cardinal Health
11.1.3.1. Overview
11.1.3.2. Product Portfolio
11.1.3.3. Profitability by Market Segments
11.1.3.4. Sales Footprint
11.1.3.5. Strategy Overview
11.1.3.5.1. Marketing Strategy
11.1.4. Terumo Corporation
11.1.4.1. Overview
11.1.4.2. Product Portfolio
11.1.4.3. Profitability by Market Segments
11.1.4.4. Sales Footprint
11.1.4.5. Strategy Overview
11.1.4.5.1. Marketing Strategy
11.1.5. Nipro Corporation
11.1.5.1. Overview
11.1.5.2. Product Portfolio
11.1.5.3. Profitability by Market Segments
11.1.5.4. Sales Footprint
11.1.5.5. Strategy Overview
11.1.5.5.1. Marketing Strategy
11.1.6. Lifelong Meditech Private Limited
11.1.6.1. Overview
11.1.6.2. Product Portfolio
11.1.6.3. Profitability by Market Segments
11.1.6.4. Sales Footprint
11.1.6.5. Strategy Overview
11.1.6.5.1. Marketing Strategy
11.1.7. EXELINT International, Co.
11.1.7.1. Overview
11.1.7.2. Product Portfolio
11.1.7.3. Profitability by Market Segments
11.1.7.4. Sales Footprint
11.1.7.5. Strategy Overview
11.1.7.5.1. Marketing Strategy
11.1.8. Vitrex Medical A/S
11.1.8.1. Overview
11.1.8.2. Product Portfolio
11.1.8.3. Profitability by Market Segments
11.1.8.4. Sales Footprint
11.1.8.5. Strategy Overview
11.1.8.5.1. Marketing Strategy
11.1.9. Retractable Technologies
11.1.9.1. Overview
11.1.9.2. Product Portfolio
11.1.9.3. Profitability by Market Segments
11.1.9.4. Sales Footprint
11.1.9.5. Strategy Overview
11.1.9.5.1. Marketing Strategy
11.1.10. Becton, Dickinson and Company
11.1.10.1. Overview
11.1.10.2. Product Portfolio
11.1.10.3. Profitability by Market Segments
11.1.10.4. Sales Footprint
11.1.10.5. Strategy Overview
11.1.10.5.1. Marketing Strategy
12. Assumptions & Acronyms Used13. Research Methodology
List of Tables
Table 1: Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 3: Market Value (US$ Million) Forecast by End Users, 2018 to 2033
Table 4: Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 6: Market Value (US$ Million) Forecast by End Users, 2018 to 2033
List of Charts
Figure 1: Market Value (US$ Million) by Type, 2023 to 2033
Figure 2: Market Value (US$ Million) by End Users, 2023 to 2033
Figure 3: Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 8: Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 9: Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 10: Market Value (US$ Million) Analysis by End Users, 2018 to 2033
Figure 11: Market Value Share (%) and BPS Analysis by End Users, 2023 to 2033
Figure 12: Market Y-o-Y Growth (%) Projections by End Users, 2023 to 2033
Figure 13: Market Attractiveness by Type, 2023 to 2033
Figure 14: Market Attractiveness by End Users, 2023 to 2033
Figure 15: Market Attractiveness by Region, 2023 to 2033
Figure 16: Market Value (US$ Million) by Type, 2023 to 2033
Figure 17: Market Value (US$ Million) by End Users, 2023 to 2033
Figure 18: Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 20: Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 23: Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 24: Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 25: Market Value (US$ Million) Analysis by End Users, 2018 to 2033
Figure 26: Market Value Share (%) and BPS Analysis by End Users, 2023 to 2033
Figure 27: Market Y-o-Y Growth (%) Projections by End Users, 2023 to 2033
Figure 28: Market Attractiveness by Type, 2023 to 2033
Figure 29: Market Attractiveness by End Users, 2023 to 2033
Figure 30: Market Attractiveness by Country, 2023 to 2033
